Fireside Chat, Interview, Roundtable, Other
A Conversation with CMS Director of Medicare Meena Seshamani | Future of Health Summit 2024
- The organization has implemented reforms to the health care system focused on treating individuals differently and expanding community health opportunities.
- Specific initiatives include district programs designed to care for people with developmental issues, chronic illnesses, children, and caregivers.
- More than 5,000 care requests were rejected by the committee, a figure cited as a standard for addressing issues within the human rights model.
- The team successfully implemented the Inflation Reduction Act, which is expected to allow the system to engage more deeply on how drugs impact child and adult health.
- A cost analysis identified seniors spending up to $15,000 annually over six years on prescription drugs as a significant area of focus for cost reduction.
- The speaker emphasized the need to navigate the "symptom cycle" with providers, patients, and health players to ensure continuous learning and system stability.
- Risk adjustment methodologies are being updated using diagnosis data from 2004 to 2019 to better anticipate costs and prevent wait times for care.
- Non-adjusted Medicaid benefits are being reviewed to allow patients to move across care plans more effectively, addressing issues with four-week benefit limits.
- New social media platforms have been created three months prior to program changes to facilitate better communication between plans and patients.
- Quality of care is being measured through patient surveys and interviews to determine if patients can stay home or require further intervention.
- The speaker noted a disconnect in "real-time" dialogue with external institutions, highlighting the need for policy changes to close regulatory loopholes.
- Behavioral health has been integrated into the Medicare program to address 400,000 potential additional conditions that fall outside traditional 10-15 minute visits.
- The team included experts from drug-pricing, pharmaceutical industries, pharmacists, health plans, and economics to negotiate and design the program.
- A deadline of September 1st was established for an international agreement related to the next round of financial presentations and AI integration.
- Future implementation timelines for the discussed programs are projected to span five to eight months, relying on feedback from patient groups, health plans, and pharmacy teams.